<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00901485</url>
  </required_header>
  <id_info>
    <org_study_id>08/H0708/16</org_study_id>
    <secondary_id>R&amp;D No. 2008/LF017B</secondary_id>
    <nct_id>NCT00901485</nct_id>
  </id_info>
  <brief_title>Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Newly Diagnosed Patients</brief_title>
  <official_title>Autotitrating Non-invasive Ventilation (NIV) Versus Standard NIV; a Randomised Crossover Trial in Patients With Newly Diagnosed Hypoventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ResMed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal Brompton &amp; Harefield NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ResMed</source>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the efficacy and tolerance of autotitrating non-invasive
      ventilation (NIV) versus standard NIV in patients with newly diagnosed nocturnal
      hypoventilation who have never experienced nocturnal, home NIV.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to compare the effect of two types of noninvasive ventilator (a small
      machine that assists breathing) in patients newly diagnosed with nocturnal hypoventilation
      who are inexperienced in the use of noninvasive ventilation (NIV). NIV is standard therapy
      for patients with nocturnal hypoventilation.

      The most common type of NIV is bilevel pressure support which assists patient breathing by
      delivering different levels of air pressure during inspiration and expiration via a mask
      covering the nose or nose and mouth. Standard bilevel NIV (VPAP™) has been further developed
      to create a new automatically adjusting NIV (AutoVPAP™). Automatically adjusting NIV varies
      the inspiratory air pressure according to the airflow rates generated by the patient. This
      may improve patient comfort, hours of NIV use and recovery time.

      Patients over the age of 18 referred to, or under follow up at, the Royal Brompton Hospital
      who require domiciliary NIV but are inexperienced with use of NIV will be considered for
      entry into this randomised crossover study. If eligible for inclusion and willing to take
      part patients will be setup on automatically adjusting NIV or standard NIV, assigned in
      random order. At the end of one month the patient will be swapped to the alternative NIV for
      a further one month of domiciliary NIV treatment. At the end of each one month treatment
      period the patient will undergo overnight polysomnography, transcutaneous CO2 monitoring and
      24 hour Holter monitoring.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>overnight mean oxygen saturation</measure>
    <time_frame>4 - 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>overnight mean transcutaneous carbon dioxide</measure>
    <time_frame>4 - 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overnight peak transcutaneous carbon dioxide</measure>
    <time_frame>4 - 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time spent with oxygen saturations &lt; 90%</measure>
    <time_frame>4 - 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Efficiency</measure>
    <time_frame>4 - 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Nocturnal Hypoventilation</condition>
  <condition>Neuromuscular Disease</condition>
  <condition>Chest Wall Disorder</condition>
  <arm_group>
    <arm_group_label>autotitrating NIV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>approximately 6 weeks using domiciliary nocturnal autotitrating non-invasive ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard non-invasive ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>approximately 6 weeks using domiciliary nocturnal standard non-invasive ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AutoVPAP</intervention_name>
    <description>Automatically titrated non-invasive ventilator, with target gross alveolar ventilation and back up respiratory rate determined by learn function. Nocturnal use for one month in patient's home.</description>
    <arm_group_label>autotitrating NIV</arm_group_label>
    <other_name>autotitrating variable positive airway pressure</other_name>
    <other_name>autotitrating NIV</other_name>
    <other_name>automatically titrating NIV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VPAPIIIST-A</intervention_name>
    <description>Standard non-invasive ventilator with pressure and respiratory rate settings determined by healthcare professional. Nocturnal use for one month in the patient's home.</description>
    <arm_group_label>Standard non-invasive ventilation</arm_group_label>
    <other_name>standard NIV</other_name>
    <other_name>standard non-invasive ventilator</other_name>
    <other_name>variable positive airway pressure</other_name>
    <other_name>VPAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  new clinical diagnosis of nocturnal hypoventilation

          -  requirement for long-term domiciliary non-invasive ventilation

          -  no previous experience with domiciliary non-invasive ventilation

        Exclusion Criteria:

          -  uncontrolled cardiac failure

          -  acute exacerbation of respiratory failure

          -  daytime resting PaO2 &lt; 7.5kPa

          -  moderate or severe bulbar weakness

          -  inability to understand rationale and/or consent form for study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anita Simonds, MD, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Brompton &amp; Harefield Hospital NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2009</study_first_submitted>
  <study_first_submitted_qc>May 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2009</study_first_posted>
  <last_update_submitted>March 21, 2012</last_update_submitted>
  <last_update_submitted_qc>March 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2012</last_update_posted>
  <responsible_party>
    <name_title>Dr Anita Simonds, Consultant in Respiratory Medicine</name_title>
    <organization>Royal Brompton &amp; Harefield Hospital NHS Trust</organization>
  </responsible_party>
  <keyword>Respiratory insufficiency</keyword>
  <keyword>Hypercapnia</keyword>
  <keyword>Hypoventilation</keyword>
  <keyword>Sleep</keyword>
  <keyword>Polysomnography</keyword>
  <keyword>Hypoxia</keyword>
  <keyword>Titration</keyword>
  <keyword>Non Invasive Ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
    <mesh_term>Hypoventilation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

